Stephen Machatha - Net Worth and Insider Trading

Stephen Machatha Net Worth

The estimated net worth of Stephen Machatha is at least $943,142 dollars as of 2024-05-23. Stephen Machatha is the Chief Development Officer of Aldeyra Therapeutics Inc and owns about 243,706 shares of Aldeyra Therapeutics Inc (ALDX) stock worth over $943,142. Details can be seen in Stephen Machatha's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephen Machatha has not made any transactions after 2024-03-12 and currently still holds the listed stock(s).

Transaction Summary of Stephen Machatha

To

Stephen Machatha Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephen Machatha owns 1 companies in total, including Aldeyra Therapeutics Inc (ALDX) .

Click here to see the complete history of Stephen Machatha’s form 4 insider trades.

Insider Ownership Summary of Stephen Machatha

Ticker Comapny Transaction Date Type of Owner
ALDX Aldeyra Therapeutics Inc 2024-03-12 Chief Development Officer

Stephen Machatha Latest Holdings Summary

Stephen Machatha currently owns a total of 1 stock. Stephen Machatha owns 243,706 shares of Aldeyra Therapeutics Inc (ALDX) as of March 12, 2024, with a value of $943,142.

Latest Holdings of Stephen Machatha

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALDX Aldeyra Therapeutics Inc 2024-03-12 243,706 3.87 943,142

Holding Weightings of Stephen Machatha


Stephen Machatha Form 4 Trading Tracker

According to the SEC Form 4 filings, Stephen Machatha has made a total of 2 transactions in Aldeyra Therapeutics Inc (ALDX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Aldeyra Therapeutics Inc is the sale of 29,768 shares on March 12, 2024, which brought Stephen Machatha around $98,532.

Insider Trading History of Stephen Machatha

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stephen Machatha Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Stephen Machatha Ownership Network

Ownership Network List of Stephen Machatha

No Data

Ownership Network Relation of Stephen Machatha


Stephen Machatha Owned Company Details

What does Aldeyra Therapeutics Inc do?

Who are the key executives at Aldeyra Therapeutics Inc?

Stephen Machatha is the Chief Development Officer of Aldeyra Therapeutics Inc. Other key executives at Aldeyra Therapeutics Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , director & President and CEO Todd C Brady , and See Remarks Bruce Greenberg .

Aldeyra Therapeutics Inc (ALDX) Insider Trades Summary

Over the past 18 months, Stephen Machatha made 2 insider transaction in Aldeyra Therapeutics Inc (ALDX) with a net sale of 41,305. Other recent insider transactions involving Aldeyra Therapeutics Inc (ALDX) include a net sale of 2,074,234 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 26,402 shares made by Bruce Greenberg , and a net sale of 183,238 shares made by Todd C Brady .

In summary, during the past 3 months, insiders sold 250,945 shares of Aldeyra Therapeutics Inc (ALDX) in total and bought 682,265 shares, with a net purchase of 431,320 shares. During the past 18 months, 3,007,444 shares of Aldeyra Therapeutics Inc (ALDX) were sold and 682,265 shares were bought by its insiders, resulting in a net sale of 2,325,179 shares.

Aldeyra Therapeutics Inc (ALDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aldeyra Therapeutics Inc Insider Transactions

No Available Data

Stephen Machatha Mailing Address

Above is the net worth, insider trading, and ownership report for Stephen Machatha. You might contact Stephen Machatha via mailing address: 131 Hartwell Avenue, Suite 320, Lexington Ma 02421.

Discussions on Stephen Machatha

No discussions yet.